Thought Leadership

Veeva Vault & Translation Management System (TMS) Integration

As pharmaceutical companies implement one or more Veeva Vault applications, it is important to consider the global aspect of content. Download our simple checklist to see if your organization could benefit from a connector between Veeva Vault and a TMS....

A Checklist for eCOA Solution Deployment: Best Practices and Considerations

Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the...

Top 10 Biotechnology Company Captures and Disseminates Insights from a Key Advisory Board Meeting

The company enlisted the support of TransPerfect to provide a medical writer with expertise in the genetic disease to transcribe the meeting in full and produce an executive summary detailing the main takeaways and discussions....

Clinical Data Services Company Launches its Statistical Webinar Series

“Another great seminar in a long line of excellence. I can only say, keep it up!”...

Global Pharma Saves $1.1M with Regulatory Translation Solution

AI-powered workflows to help reduce costs and timelines while being scalable to the large volume of content required....

Leveraging the Patent Priority Date: A Life Sciences Focus

This TransPerfect Life Sciences blog post provides insights into the strategic importance of patent priority dates in the life sciences sector. ...

Content Automation to Meet MDR & IVDR Requirements

Marc Miller, President of TransPerfect's Medical Device Solutions chatted with experts from Takeda Pharmaceuticals & QServe to learn about MDR & IVDR labeling compliance while cutting risk, cost, & turnaround by using structured content, process automation, &...

Leading Japanese Pharma Company Authors High-Quality Regulatory Documentation

TransPerfect provided medical writing support with subject matter expertise and key regulatory experience to produce high-quality ICFs and a protocol....